BKL: Blackmores Limited - Summary | Jitta

Blackmores Limited

AUS:BKL

Notice
Stock data is unavailable or the company’s delisted.
Price
AU$94.73
Loss Chance
49.4%
4.56JITTA SCORE
242.34%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (57)
Recent Business Performance (53)
Financial Strength (87)
Return to Shareholders (31)
Competitive Advantage (33)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
Interest Coverage RatioVery Good
Revenue and EarningRevenue decline from 2019-2022
Operating MarginInconsistent
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
4.56
242.34%
1.55
76.51%
1.55
76.51%
n/a
n/a
n/a
n/a
n/a
n/a
COMPANY DESCRIPTION
Blackmores Limited develops, sells, and markets natural health products for humans and animals in Australia, New Zealand, Asia, China, and India. The company offers vitamins, and herbal and mineral nutritional supplements. It also provides products for various conditions related to arthritis, joints, bones, and muscles; brain health; cold, flu, and immunity; digestive health; energy and exercise; everyday health; and eye health. In addition, the company offers products in the areas of fish and nutritional oils; heart and circulation; infant nutrition; kids health; men's health; multivitamins; nails, hair, and skin; pet health; probiotics; pregnancy and preconception; stress relief and sleep support; weight management; wellbeing management; and women's health. It provides its products through retail and online channels. The company was founded in 1930 and is headquartered in Sydney, Australia. As of August 10, 2023, Blackmores Limited operates as a subsidiary of Kirin Health Science Australia Pty Ltd.